TVWM
TMO icon

Tower View Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Tower View Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.8K Sell
112
-11
-9% -$5.97K 0.03% 93
2025
Q4 		$71.5K Hold
123
– – 0.04% 80
2025
Q3 		$59.8K Sell
123
-52
-30% -$24.2K 0.03% 79
2025
Q2 		$70.8K Buy
175
+1
+0.6% +$418 0.04% 90
2025
Q1 		$86.8K Sell
174
-87
-33% -$47.1K 0.05% 64
2024
Q4 		$136K Sell
261
-2
-0.8% -$1.1K 0.07% 63
2024
Q3 		$163K Hold
263
– – 0.09% 58
2024
Q2 		$145K Buy
263
+26
+11% +$14.9K 0.08% 60
2024
Q1 		$138K Hold
237
– – 0.08% 66
2023
Q4 		$126K Hold
237
– – 0.08% 62
2023
Q3 		$120K Hold
237
– – 0.08% 62
2023
Q2 		$124K Hold
237
– – 0.08% 61
2023
Q1 		$136K Hold
237
– – 0.09% 65
2022
Q4 		$130K Hold
237
– – 0.09% 64
2022
Q3 		$120K Buy
237
+1
+0.4% +$560 0.09% 66
2022
Q2 		$128K Sell
236
-17
-7% -$9.36K 0.09% 67
2022
Q1 		$150K Hold
253
– – 0.08% 81
2021
Q4 		$169K Hold
253
– – 0.09% 81
2021
Q3 		$145K Hold
253
– – 0.08% 79
2021
Q2 		$128K Hold
253
– – 0.06% 85
2021
Q1 		$115K Buy
253
+17
+7% +$8.11K 0.06% 89
2020
Q4 		$110K Hold
236
– – 0.06% 87
2020
Q3 		$104K Sell
236
-15
-6% -$6.2K 0.07% 78
2020
Q2 		$91K Sell
251
-9
-3% -$3.02K 0.07% 75
2020
Q1 		$74K Sell
260
-15
-5% -$4.73K 0.07% 69
2019
Q4 		$89K Hold
275
– – 0.07% 74
2019
Q3 		$80K Hold
275
– – 0.07% 74
2019
Q2 		$81K Hold
275
– – 0.07% 69
2019
Q1 		$75K Buy
275
+57
+26% +$14.2K 0.07% 70
2018
Q4 		$49K Hold
218
– – 0.05% 76
2018
Q3 		$53K Buy
218
+1
+0.5% +$230 0.05% 88
2018
Q2 		$45K Hold
217
– – 0.04% 90
2018
Q1 		$45K Hold
217
– – 0.05% 90
2017
Q4 		$41K Buy
+217
New +$41.6K 0.04% 97

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tower View Wealth Management's TMO Position: Q1 2026 in Review

Tower View Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 8.9% in Q1 2026, selling an estimated $5.97K and leaving 112 shares worth $54.8K. The position accounts for 0.03% of the portfolio, ranked #93.

Tower View Wealth Management first reported a position in TMO in Q4 2017 and has held it in 34 quarters since. The position peaked at $169K in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Tower View Wealth Management held 112 shares of Thermo Fisher Scientific worth $54.8K as of Q1 2026.
  • Tower View Wealth Management sold 11 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.97K.
  • Thermo Fisher Scientific made up 0.03% of Tower View Wealth Management's portfolio in Q1 2026, its #93 holding.
  • Tower View Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 34 quarters since.
  • Tower View Wealth Management's Thermo Fisher Scientific position peaked at $169K in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Tower View Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.